Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Surgalign Holdings stock

SRGA
US86882C1053
A2P953

Price

0.02
Today +/-
+0
Today %
+0 %

Surgalign Holdings stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Surgalign Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Surgalign Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Surgalign Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Surgalign Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Surgalign Holdings Stock Price History

DateSurgalign Holdings Price
10/2/20230.02 undefined
9/29/20230.01 undefined

Surgalign Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Surgalign Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Surgalign Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Surgalign Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Surgalign Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Surgalign Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Surgalign Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Surgalign Holdings’s growth potential.

Surgalign Holdings Revenue, EBIT and net profit per share

DateSurgalign Holdings RevenueSurgalign Holdings EBITSurgalign Holdings Net Income
2028e142.54 M undefined0 undefined0 undefined
2027e109.36 M undefined-20.53 M undefined0 undefined
2026e85.61 M undefined-44.19 M undefined0 undefined
2025e115.17 M undefined-18.85 M undefined-69.4 M undefined
2024e57.62 M undefined-26.26 M undefined-74.66 M undefined
2023e53.15 M undefined-45.39 M undefined-73.48 M undefined
202281.98 M undefined-70.44 M undefined-54.61 M undefined
202190.5 M undefined-53.9 M undefined-84.65 M undefined
2020101.75 M undefined-78.59 M undefined-33.78 M undefined
2019117.4 M undefined-67.6 M undefined-211.6 M undefined
201892.1 M undefined-54 M undefined-5.2 M undefined
2017279.6 M undefined11.3 M undefined2.5 M undefined
2016272.9 M undefined-8.1 M undefined-17.9 M undefined
2015282.3 M undefined27.2 M undefined11.6 M undefined
2014262.8 M undefined10.6 M undefined-400,000 undefined
2013198 M undefined-16.8 M undefined-19.2 M undefined
2012178.1 M undefined14.6 M undefined8.4 M undefined
2011169.3 M undefined11.9 M undefined8.4 M undefined
2010166.2 M undefined7.3 M undefined-129.4 M undefined
2009164.5 M undefined9.3 M undefined5.9 M undefined
2008146.6 M undefined6.5 M undefined-100 M undefined
200794.2 M undefined1.4 M undefined-2.1 M undefined
200674 M undefined-13.3 M undefined-11.1 M undefined
200575.2 M undefined-8.6 M undefined-5.6 M undefined
200492.7 M undefined10.1 M undefined6.2 M undefined
200375.5 M undefined6.8 M undefined6.4 M undefined

Surgalign Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023e2024e2025e2026e2027e2028e
357312267697592757494146164166169178198262282272279921171019081535711585109142
-108.5767.12-45.082.998.7022.67-18.48-1.3327.0355.3212.331.221.815.3311.2432.327.63-3.552.57-67.0327.17-13.68-10.89-10.00-34.577.55101.75-26.0928.2430.28
2.8615.0721.3141.7934.7842.6740.2225.3325.6839.3646.5846.9545.7845.5647.7540.4050.7652.8448.5350.9063.0471.7956.4466.6749.3875.4770.1834.7847.0636.7028.17
11126282432371919376877767785801331491321425884576040000000
-434-5-1366-5-11-2-1005-12988-19011-172-5-211-33-84-54-73-74-69000
--175.0033.33-225.00160.00-146.15--183.33120.00-81.824,900.00-105.00-2,680.00-106.20--337.50---254.55-111.76-350.004,120.00-84.36154.55-35.7135.191.37-6.76---
3.716.620.321.822.42727.127.829.829.849.954.854.755.456.156.356.758.658.260.66170.22.484.096.56000000
-------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Surgalign Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Surgalign Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
                                                 
3.97.534.913.59.810.111.525.615.518.620.117.428.246.249.718.715.712.613.822.410.95.643.9651.2916.3
5.915.527.321.714.15.99.599.39.814.722.220.120.721.731.838.847.241.535.148.459.327.119.216.06
00000000002040000009.83.92.88.637.435.71
4.416.223.429.328.641.740.438.53739.875.293.987.376.676.5106.1113.5118.7119.7111.9107.5124.122.8426.217.71
0.91.93.48.924.221.47.612.111.420.319.719.419.416.218.730.129.513.25.26.44.841.652.550.94
15.141.18973.476.779.16985.273.288.5131.7152.9159159.7166.6186.7197.5191.7180.2185.6175.5195.8104.18106.6756.71
4.15.814.836.150.643.744.444.54135.547.646.643.344.549.674.7778583.379.678721.951.823.02
0005.3000000000000000000000
0000000000000000000000000
00.20.60.90.81.223.268.512.712.315.613.713.833.830.326.22423.126.410.5000
002.82.62.62.92.92.92.90.2134.4134.7002.154.954.954.954.946.259.855.4000
0.11.31.30.410.49.66.36.46.63.47.687.712.29.419.818.522.925.611.421.510.816.5815.3110.51
4.27.319.545.364.457.455.65756.547.6202.3201.666.670.474.9183.2180.7189187.8160.3185.7148.718.5217.1313.53
19.348.4108.5118.7141.1136.5124.6142.2129.7136.1334354.5225.6230.1241.5369.9378.2380.7368345.9361.2344.5122.7123.870.24
                                                 
6.616.6000000000.10.10.10.10.149.652.956.460.16466.366.50.0810.0110.01
0.50.471.672.299.2102102.8126.6129.8133.6403.7406.3408.8411.7414.5415.4415.7417.7417.4429.5433.1498.4517.12585.52607.25
-4.1-1.23.3-2.2-15.7-9.4-3.2-8.8-19.9-22-122-116.1-245.5-237.1-228.7-246.6-243.9-228.9-243.3-237.1-237.4-451.2-484.96-569.61-624.22
-4.3-0.4-2.4-2.2-0.9-0.30000-0.8-0.4-1.4-2.2-1.8-0.8-3.9-7-8.3-6.3-7.3-7.6-2.42-1.82-2.84
0000000000000000000000000
-1.315.472.567.882.692.399.6117.8109.9111.6281289.9162172.5184.1217.6220.8238.2225.9250.1254.7106.129.8324.09-9.8
13.321.122.42226.518.97.87.17.97.616.919.812.611.111.923.226.820.426.118.326.330.113.4210.27.71
1.12.24.87.47.15.94.76.26.38.115.911.514.21516.622.323.428.12225.624.733.321.6443.3513.15
0.20.20.30.30.40.40.20.100.62.92.75.698.85.57.25.44.74.94.92.711.760.480.3
02.8015.315.112.100004.22.10000000000000
0.40.91.20.71.91.62.22.32.31.51.61.91.10.40.11.36.55.96.14.30174.2000
1527.228.745.75138.914.915.716.517.841.53833.535.537.452.363.959.858.953.155.9240.346.8254.0421.15
1.523.70.72.30.67.95.63.41.93.2111.90.1067.769.473.477.342.149.1009.9810.19
0000001.22.4000.10.10.20.30.50000000000
4.23.93.74.55.24.51.10.804.68.215.528.321.519.532.224.19.86.95.26.43.151.7141.5354.63
5.75.97.45.27.55.110.28.83.46.511.526.630.421.92099.993.583.284.247.355.53.151.7151.5164.82
20.733.136.150.958.54425.124.519.924.35364.663.957.457.4152.2157.4143143.1100.4111.4243.498.53105.5685.97
19.448.5108.6118.7141.1136.3124.7142.3129.8135.9334354.5225.9229.9241.5369.8378.2381.2369350.5366.1349.5128.36129.6576.17
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Surgalign Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Surgalign Holdings's financial health and stability.

Assets

Surgalign Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Surgalign Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Surgalign Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Surgalign Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-424-5-1366-5-11-2-995-12988-17214-146-3-211-33-126-54
00123444557778712151616141422622
0-10-2002-3-6-1011-10-1105-313-417-10-1
7-9-17-105-13-170-2-3-16-20139214-14-33-2-11-9-15-8-17-5
0021110003118107213531-13519-2020178-51897
00002100000000001113371400
0110-20000000003203012-6-1772
3-6-9-46-1-2-1-370-4292720-46915217-9-88-51-52
-1-2-10-23-15-1-2-5-4-2-6-4-7-8-17-142-16-18-17-14-14-16-14-14-7
-1-2-10-28-15511-5-3-30-4-7-8-17-142-16-18-1738-32-116390-24-7
000-5061400060000000052-18-99404-100
0000000000000000000000000
02-111-2-4-5-2-2-205-12-2068634-373121-19400
61048026102300200100020510-678228
21246115-2-721-2-126-11-10115763-324120-2638224
-3000-180-200000000470000-10-10-3
0000000000000000000000000
3327-21-30114-1031-210173-30-3-318-11-5387-34
1.51-9.35-19.56-27.57-9.19-3.58-5.69-7.28-8.074.89-7.45-9.1822.3319.292.94-146.68-9.42-9.24-2.63-12.112.51-25.89-102.08-65.86-59.37
0000000000000000000000000

Surgalign Holdings stock margins

The Surgalign Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Surgalign Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Surgalign Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Surgalign Holdings's sales revenue. A higher gross margin percentage indicates that the Surgalign Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Surgalign Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Surgalign Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Surgalign Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Surgalign Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Surgalign Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Surgalign Holdings Margin History

Surgalign Holdings Gross marginSurgalign Holdings Profit marginSurgalign Holdings EBIT marginSurgalign Holdings Profit margin
2028e49.14 %0 %0 %
2027e49.14 %-18.77 %0 %
2026e49.14 %-51.62 %0 %
2025e49.14 %-16.37 %-60.26 %
2024e49.14 %-45.57 %-129.56 %
2023e49.14 %-85.39 %-138.24 %
202249.14 %-85.92 %-66.61 %
202167.1 %-59.56 %-93.54 %
202056.75 %-77.24 %-33.2 %
201972.06 %-57.58 %-180.24 %
201863.52 %-58.63 %-5.65 %
201750.97 %4.04 %0.89 %
201648.48 %-2.97 %-6.56 %
201553.03 %9.64 %4.11 %
201450.91 %4.03 %-0.15 %
201340.45 %-8.48 %-9.7 %
201247.84 %8.2 %4.72 %
201145.6 %7.03 %4.96 %
201045.73 %4.39 %-77.86 %
200947.11 %5.65 %3.59 %
200846.93 %4.43 %-68.21 %
200740.02 %1.49 %-2.23 %
200626.08 %-17.97 %-15 %
200526.2 %-11.44 %-7.45 %
200440.13 %10.9 %6.69 %
200343.31 %9.01 %8.48 %

Surgalign Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Surgalign Holdings earnings per share therefore indicates how much revenue Surgalign Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Surgalign Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Surgalign Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Surgalign Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Surgalign Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Surgalign Holdings Revenue, EBIT and net profit per share

DateSurgalign Holdings Sales per ShareSurgalign Holdings EBIT per shareSurgalign Holdings Earnings per Share
2028e21.52 undefined0 undefined0 undefined
2027e16.51 undefined0 undefined0 undefined
2026e12.92 undefined0 undefined0 undefined
2025e17.39 undefined0 undefined-10.48 undefined
2024e8.7 undefined0 undefined-11.27 undefined
2023e8.02 undefined0 undefined-11.09 undefined
202212.51 undefined-10.75 undefined-8.33 undefined
202122.15 undefined-13.19 undefined-20.72 undefined
202041.03 undefined-31.69 undefined-13.62 undefined
20191.67 undefined-0.96 undefined-3.01 undefined
20181.51 undefined-0.89 undefined-0.09 undefined
20174.61 undefined0.19 undefined0.04 undefined
20164.69 undefined-0.14 undefined-0.31 undefined
20154.82 undefined0.46 undefined0.2 undefined
20144.63 undefined0.19 undefined-0.01 undefined
20133.52 undefined-0.3 undefined-0.34 undefined
20123.17 undefined0.26 undefined0.15 undefined
20113.06 undefined0.21 undefined0.15 undefined
20103.04 undefined0.13 undefined-2.37 undefined
20093 undefined0.17 undefined0.11 undefined
20082.94 undefined0.13 undefined-2 undefined
20073.16 undefined0.05 undefined-0.07 undefined
20062.48 undefined-0.45 undefined-0.37 undefined
20052.71 undefined-0.31 undefined-0.2 undefined
20043.42 undefined0.37 undefined0.23 undefined
20032.8 undefined0.25 undefined0.24 undefined

Surgalign Holdings business model

Surgalign Holding Inc. is a global leading provider of innovative solutions for spinal surgery. The company specializes in the development, manufacturing, and marketing of devices and products for spinal surgery. Surgalign Holding Inc. is headquartered in Deerfield, Illinois, USA and has branches in Europe, Asia, the Middle East, and other parts of the world. Surgalign Holdings is one of the most popular companies on Eulerpool.com.

Surgalign Holdings SWOT Analysis

Strengths

  • Strong market position: Surgalign Holdings Inc holds a significant position in the orthopedic surgical solutions market, with a wide range of innovative products.
  • Robust research and development capabilities: The company invests heavily in R&D, allowing it to constantly improve its product offerings and stay ahead of competitors.
  • Strategic partnerships: Surgalign has successfully formed strategic collaborations with leading healthcare providers, enhancing its market presence and customer base.
  • Strong financial performance: The company has a history of solid financial performance, with consistent revenue growth and healthy profit margins.

Weaknesses

  • High reliance on a limited number of products: Surgalign's success is heavily dependent on a few key products, leaving it vulnerable to any changes in demand or market conditions.
  • Limited geographical reach: The company's operations are primarily focused in certain regions, which restricts its exposure to potential growth markets.
  • Relatively small market share: Surgalign faces intense competition from larger, more established players in the orthopedic surgical solutions industry, affecting its market share.

Opportunities

  • Growing global demand for orthopedic solutions: The increasing prevalence of musculoskeletal disorders and an aging population present significant opportunities for Surgalign to expand its customer base.
  • Technological advancements: The integration of advanced technologies, such as robotics and artificial intelligence, in surgical solutions opens up new avenues for innovation and product development.
  • Expansion into emerging markets: Surgalign can explore untapped markets in developing countries, where the demand for orthopedic surgical solutions is expected to rise.

Threats

  • Intense competition: The industry is highly competitive, with numerous well-established companies competing for market share, which may limit Surgalign's growth potential.
  • Regulatory challenges: Compliance with strict regulatory requirements and obtaining necessary approvals can pose challenges and delay product launches.
  • Economic downturns: Economic downturns could impact healthcare spending and potentially reduce demand for expensive surgical solutions.

Surgalign Holdings Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Surgalign Holdings Revenue by Segment

Segmente2019
Spine118.99 M _USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Surgalign Holdings Revenue by Segment

Segmente2019
Oem Segment189.4 M _USD
Original Equipment Manufacturers124.18 M _USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Surgalign Holdings Revenue by Segment

Segmente2019
U S Spine97.63 M _USD
Sports55.34 M _USD
International21.36 M _USD
Foreign9.87 M _USD

Surgalign Holdings Revenue by Region

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Surgalign Holdings Revenue by Segment

DateDomesticInternational
202268.65 M USD13.33 M USD
202177.93 M USD12.57 M USD
202085.61 M USD16.14 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Surgalign Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Surgalign Holdings historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Surgalign Holdings shares outstanding

The number of shares was Surgalign Holdings in 2024 — This indicates how many shares 6.555 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Surgalign Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Surgalign Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Surgalign Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Surgalign Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Surgalign Holdings stock splits

In Surgalign Holdings's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Surgalign Holdings.

Surgalign Holdings shareholders

%
Name
Stocks
Change
Date
11.79044 % Armistice Capital LLC781,000781,00012/31/2022
9.57944 % Lewicki (Pawel Ph.D.)634,543165,7921/26/2022
5.07055 % Siemionow (Krzysztof)335,874335,8741/27/2022
4.94125 % Atria Wealth Solutions, Inc.327,309142,56112/31/2022
2.68407 % The Vanguard Group, Inc.177,7938212/31/2022
2.35602 % Rich (Terry M)156,063-5402/7/2023
1.67371 % Omega Advisors, Inc.110,86759,59012/31/2021
1.08443 % Cerity Partners LLC71,83371,83312/31/2022
0.96528 % Durall (William Scott)63,940-1782/7/2023
0.87910 % Hightower Advisors, LLC58,232-26,66512/31/2022
1
2
3
4
5
...
10

Surgalign Holdings Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Arkema Stock
Arkema
SupplierCustomer0,56-0,320,560,69-0,26-0,79
Aziyo Biologics A Stock
Aziyo Biologics A
SupplierCustomer0,370,02-0,25-0,150,73
Pro-Dex Stock
Pro-Dex
SupplierCustomer-0,44-0,280,730,930,900,30
1

Most common questions regarding Surgalign Holdings

What values and corporate philosophy does Surgalign Holdings represent?

Surgalign Holdings Inc represents core values of innovation, quality, and patient-focused care. With a strong commitment to advancing spine technology, Surgalign aims to improve patient outcomes and enhance surgical techniques. The company's corporate philosophy revolves around driving positive change in the medical industry through collaboration and integrity. Surgalign's dedication to precision and excellence is evident in its comprehensive range of products and solutions for spinal surgery. As a trusted leader in the field, Surgalign prioritizes customer satisfaction and sustainable growth, positioning itself as a reliable and forward-thinking partner for healthcare professionals worldwide.

In which countries and regions is Surgalign Holdings primarily present?

Surgalign Holdings Inc is primarily present in the United States.

What significant milestones has the company Surgalign Holdings achieved?

Surgalign Holdings Inc has achieved several significant milestones. Firstly, the company successfully completed its initial public offering (IPO) and got listed on the Nasdaq stock exchange. Surgalign Holdings Inc also expanded its product portfolio by acquiring technology platforms like R&D Surgical Ltd and Holo Surgical Inc. Moreover, the company received FDA clearance for its flagship technology, the Surgalign Cervical Spinal Alignment System, which offers innovative solutions for better patient outcomes. Surgalign Holdings Inc continues to focus on research and development to introduce advanced spine solutions, improving surgical procedures globally.

What is the history and background of the company Surgalign Holdings?

Surgalign Holdings Inc is a leading global medical technology company that specializes in providing innovative spinal solutions. Founded in 2015, Surgalign is committed to improving patient outcomes through the development and commercialization of advanced spinal implants and procedural solutions. With a focus on precision, quality, and reliability, Surgalign offers a comprehensive portfolio of products designed to address various spinal conditions, from degenerative disc disease to complex deformities and trauma. The company's history showcases a dedication to research and development, leading to the introduction of cutting-edge technologies that enhance surgeons' capabilities and ultimately improve patients' lives. Surgalign Holdings Inc continues to strive towards making a positive impact in the field of spine surgery.

Who are the main competitors of Surgalign Holdings in the market?

The main competitors of Surgalign Holdings Inc in the market are Medtronic, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings, and NuVasive Inc.

In which industries is Surgalign Holdings primarily active?

Surgalign Holdings Inc primarily operates in the healthcare and medical devices industry. As a leading global surgical solutions provider, Surgalign focuses on developing and commercializing innovative technology for spine procedures. With a wide range of transformative solutions, Surgalign aims to enhance patient outcomes and improve surgical efficiencies. From developing advanced products for spinal fixation and interbody fusion to precision surgical instruments and robotics, Surgalign caters to the needs of spine surgeons and hospitals worldwide. Through its expertise and commitment to innovation, Surgalign continues to play a significant role in advancing the field of spine surgery.

What is the business model of Surgalign Holdings?

The business model of Surgalign Holdings Inc focuses on developing, manufacturing, and commercializing advanced spine surgery technology. Surgalign aims to improve patient outcomes and enhance surgeon efficiency by combining innovative product offerings with cutting-edge digital solutions. By collaborating with leading surgeons, investing in research and development, and delivering high-quality products, Surgalign strives to address the evolving needs of the spine surgery market. The company's dedication to providing innovative solutions and industry-leading technologies positions Surgalign as a trusted partner for surgeons and healthcare professionals in delivering optimal spinal care.

What is the P/E ratio of Surgalign Holdings 2025?

The Surgalign Holdings P/E ratio is -0.

What is the P/S ratio of Surgalign Holdings 2025?

The Surgalign Holdings P/S ratio is 0.

What is the Quality Investing of Surgalign Holdings?

The Quality Investing for Surgalign Holdings is 2/10.

What is the revenue of Surgalign Holdings 2025?

The expected Surgalign Holdings revenue is 115.17 M USD.

How high is the profit of Surgalign Holdings 2025?

The expected Surgalign Holdings profit is -69.4 M USD.

What is the business model of Surgalign Holdings

Surgalign Holdings Inc is a leading provider of medical products and surgical solutions for various healthcare areas such as spinal surgery, orthopedics, and traumatology. The company offers its customers a wide range of innovative products based on advanced technologies and modern materials. One of the main divisions at Surgalign is products for spinal surgery. Here, the company offers a wide range of devices and instruments for the surgical treatment of various spinal conditions such as scoliosis or herniated discs. This includes implantable devices such as vertebral body replacement parts or screws for spinal fusion. Another important area for Surgalign is its international activities. The company operates in numerous countries and is known for serving customers worldwide with high-quality products and excellent service. This includes subsidiaries in Europe, Asia, and the USA, as well as effective logistics that ensure fast and reliable delivery of products. Furthermore, the company prides itself on being at the cutting edge of technology and introducing innovative products to the market. These include solutions such as the Surgalign C3 technology used in spinal fusion or the SImmetry Sacroiliac Joint Fusion System, which enables minimally invasive treatment of conditions in the sacroiliac area. In addition to its strong products, Surgalign also offers a wide range of services. These include training programs for doctors and medical personnel, as well as interactive solutions such as apps to support patients on their path to recovery and in postoperative rehabilitation. The goal is to provide patients with the best possible treatment and care and enable them to have a fast and sustainable healing process. Overall, Surgalign's business model is focused on technology-based medical care. The company pursues a customer-oriented strategy with quality, safety, and innovation at its core. With a broad portfolio of products and services and a strong international network, the company is a reliable partner for doctors, hospitals, and patients worldwide. The answer is: Surgalign Holdings Inc is a leading provider of medical products and surgical solutions for various healthcare areas such as spinal surgery, orthopedics, and traumatology. The company offers a wide range of innovative products based on advanced technologies and modern materials. They also provide training programs, interactive solutions, and strive to provide the best possible treatment and care for patients.

What is the Surgalign Holdings dividend?

Surgalign Holdings pays a dividend of 0 USD distributed over payouts per year.

How often does Surgalign Holdings pay dividends?

The dividend cannot currently be calculated for Surgalign Holdings or the company does not pay out a dividend.

What is the Surgalign Holdings ISIN?

The ISIN of Surgalign Holdings is US86882C1053.

What is the Surgalign Holdings WKN?

The WKN of Surgalign Holdings is A2P953.

What is the Surgalign Holdings ticker?

The ticker of Surgalign Holdings is SRGA.

How much dividend does Surgalign Holdings pay?

Over the past 12 months, Surgalign Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surgalign Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Surgalign Holdings?

The current dividend yield of Surgalign Holdings is .

When does Surgalign Holdings pay dividends?

Surgalign Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surgalign Holdings?

Surgalign Holdings paid dividends every year for the past 0 years.

What is the dividend of Surgalign Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surgalign Holdings located?

Surgalign Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surgalign Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surgalign Holdings from 1/29/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/29/2025.

When did Surgalign Holdings pay the last dividend?

The last dividend was paid out on 1/29/2025.

What was the dividend of Surgalign Holdings in the year 2024?

In the year 2024, Surgalign Holdings distributed 0 USD as dividends.

In which currency does Surgalign Holdings pay out the dividend?

The dividends of Surgalign Holdings are distributed in USD.

All fundamentals about Surgalign Holdings

Our stock analysis for Surgalign Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgalign Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.